nps-568 has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Aly, Z | 1 |
| Amann, K; Odoni, G; Ogata, H; Orth, SR; Ritz, E | 1 |
| Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H | 1 |
2 review(s) available for nps-568 and Cardiovascular Diseases
| Article | Year |
|---|---|
The new role of calcimimetics as vasculotropic agents.
Topics: Aniline Compounds; Calcinosis; Calcium; Cardiovascular Diseases; Cinacalcet; Humans; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing | 2009 |
CKD-MBD: impact on management of kidney disease.
Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins | 2007 |
1 other study(ies) available for nps-568 and Cardiovascular Diseases
| Article | Year |
|---|---|
Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors.
Topics: Aniline Compounds; Animals; Blood Pressure; Calcium; Cardiovascular Diseases; Disease Progression; Hyperparathyroidism, Secondary; Kidney; Lipid Metabolism; Male; Models, Animal; Myocardium; Parathyroidectomy; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Risk Factors; Ventricular Remodeling | 2003 |